Live Breaking News & Updates on Pressure enabled drug delivery

Stay updated with breaking news from Pressure enabled drug delivery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial Results

TriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Exchange-commission , Trisalus-life-sciences , Nasdaq , Linkedin , Twitter , See-the-company-quarterly-report-on-form , Salus-life-sciences , Unaudited-fourth-quarter , Full-year , Infusion-system , Pressure-enabled-drug-delivery

TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors

DENVER--(BUSINESS WIRE)--Feb 29, 2024--

United-states , Mary-szela , Trinav-smartvalve , Stevenc-katz , Centers-for-medicare , Current-medical-research , Nasdaq , Linkedin , Twitter , Trisalus-life-sciences , Salus-life-sciences , Chief-executive-officer

Baltimore's Haystack Oncology, TriSalus Life Sciences to develop liver cancer treatment

Baltimore's Haystack Oncology, TriSalus Life Sciences to develop liver cancer treatment
thedailyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailyrecord.com Daily Mail and Mail on Sunday newspapers.

Quest-diagnostics , Trisalus-life-sciences , Haystack-oncology , Pressure-enabled-drug-delivery ,

Haystack Oncology, developer of Haystack MRD™, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus' TLR9 agonist in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and pancreatic adenocarcinoma

BALTIMORE, Jan. 22, 2024 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics company and developer of best-in-class personalized MRD technology , has entered a research collaboration with...

Helsinki , Eteläuomen-läi , Finland , Hamburg , Germany , United-states , Maryland , Baltimore , Americans , Dan-edelstein , Steven-katz , Research-use

TriSalus Reports Third Quarter 2023 Financial Results and Provides Business Update

Completed merger with MedTech Acquisition Corporation and started public trading August 11th

Reported 3Q23 revenues of $5.2 million in 3Q23, up 32% over prior year and nine-month year to date net...

Steven-katz , Jodi-devlin , Mary-szela , Trisalus-life-sciences-inc , Twitter , Linkedin , Trisalus-life-sciences , Nasdaq , Society-for-immunotherapy-of-cancer , Exchange-commission , Infusion-system , Pressure-enabled-drug-delivery

Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Developmen

– New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment by enabling performance of the TLR9 agonist, SD-101, in metastatic uveal melanoma, consistent with an earlier presentation from pancreatic adenocarcinoma trial –– Median Progression-Free Survival was 1...

Texas , United-states , Denver , Colorado , Stevenc-katz , Sapna-patel , Trisalu-trinav , Exchange-commission , Society-of-immunotherapy , Nasdaq , Linkedin , Twitter

Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications

– New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment by enabling performance of the TLR9 agonist, SD-101, in metastatic uveal...

Texas , United-states , Stevenc-katz , Trisalu-trinav , Sapna-patel , Twitter , Exchange-commission , University-of-texas-md-anderson-cancer-center , Trisalus-life-sciences , Nasdaq , Linkedin , Society-of-immunotherapy

TriSalus Life Sciences Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

– New data from PERIO-03 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment by enabling performance of a TLR9 agonist in pancreatic tumors –

...

Texas , United-states , Trisalu-trinav , Michaels-lee , Stevenc-katz , Twitter , Nasdaq , Trisalus-life-sciences , Exchange-commission , Society-of-immunotherapy , University-of-texas-md-anderson-cancer-center , Linkedin

TriSalus Life Sciences Announces Late Breaker and Additional Data Presentations on Liver Metastases and Pancreatic Cancer at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

TriSalus Life Sciences® Inc., , an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today announced...

California , United-states , Texas , San-diego , Chandrac-ghosh , Sapanp-patel , Michaels-lee , Twitter , University-of-texas-md-anderson-cancer-center , Nasdaq , Trisalus-life-sciences

TriSalus Life Sciences Completes Merger with MedTech Acquisition Corporation

TriSalus Life Sciences Completes Merger with MedTech Acquisition Corporation
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Joele-frank , Wilkinson-brimmer-katcher , Kerry-hicks , Davidj-matlin , James-jim-alecxih , Kelly-martin , Aaron-palash-allison-sobel , Mary-szela , Sean-murphy , Raymond-james , Chris-dewey , Linkedin